Solving the Uncomfortable Truth
Surgeons Face Every Day

Until now, surgeons had no way of knowing during surgery whether blood flow distribution (both perfusion and flow) had actually been achieved. Instinct, experience, and the human eye were the best options they had. But not anymore.

Now, with Certes™ by Perfusio™, surgeons can see perfusion and blood flow in real time – as it happens.

Armed with accurate data, they can be absolutely certain what steps are needed next to achieve the best possible outcomes for their patients.

Certes is:

  • Accurate — Objective data
  • Fast — Real time vs. 4-6 min. of waiting for dyes and contrast agents
  • Safe — Non-contact vs. invasive fluorescence imaging
  • Efficient — Repeat as often as needed

ACCURATE

Objective data

SAFE

Non-contact vs. invasive fluorescence imaging

FAST

Real time vs. 4-6 min. of waiting for dyes and contrast agents

EFFICIENT

Repeat as often as needed

ACCURATE

Objective data

SAFE

Non-contact vs. invasive fluorescence imaging

FAST

Real time vs. 4-6 min. of waiting for dyes and contrast agents

EFFICIENT

Repeat as often as needed

Our proprietary software analyzes every image and provides quantitative blood flow distribution data.

  • This unique combination of real-time imaging and analysis has never been available before.
  • Future predictive analytics will give surgeons objective data.
  • And the best part? Repeat imaging as often as needed.

Our Innovative Platform Is Designed to Deliver …

Patients:

Safer procedures and better outcomes

Physicians:

Better decision-making at the point of care with automatic, on-screen visualization

Provider Facilities:

Fewer unnecessary complications, higher quality of care, greater patient satisfaction

Payers:

Sustainable reduction in complications, lower-cost care paths, better defined accountable surgical care practice

Our Innovative Platform Is Designed to Deliver …

Patients:

Safer procedures and better outcomes

Physicians:

Better decision-making at the point of care with automatic, on-screen analytics

Provider Facilities:

Fewer unnecessary complications, higher quality of care, greater patient satisfaction

Payers:

Cost-effective with fewer repeat procedures, readmissions, and corrective follow-up care

Case Study: Gastric Tube in Preparation for Esophageal Replacement

Improved Outcomes Case Study 1

Near-Infrared Fluorescence (NIRF) vs. Certes

This intraoperative assessment of gastric tube perfusion shows the advantages of using Certes instead of standard near-infrared fluorescence (NIRF). During this surgery, NIRF imaging required the injection of ICG dye, which binds to blood proteins and over time circulates to target the tissue of interest. With NIRF illumination, ICG fluoresces in blood and tissue to illustrate perfusion in the gastric tube.

Improved Outcomes Case Study 1

Near-Infrared Fluorescence (NIRF) vs. Certes

This intraoperative assessment of gastric tube perfusion shows the advantages of using Certes instead of standard near-infrared fluorescence (NIRF). During this surgery, NIRF imaging required the injection of ICG dye, which binds to blood proteins and over time circulates to target the tissue of interest. With NIRF illumination, ICG fluoresces in blood and tissue to illustrate perfusion in the gastric tube.

Improved Outcome Case Study 2

This procedure demonstrates the necessity of accurate visualization.

Recent research shows that 63% of esophageal replacement procedures result in postsurgical complications — primarily, leakage, stenosis, and poor vascularization. Since this procedure is needed frequently in patients with cancer, strictures, perforation, lye ingestion, Barrett’s esophagus, recurrent tracheoesophageal fistulas, and achalasia, accuracy is vital.

Improved Outcome Case Study 2

This procedure demonstrates the necessity of accurate visualization.

Recent research shows that 63% of esophageal replacement procedures result in postsurgical complications — primarily, leakage, stenosis, and poor vascularization. Since this procedure is needed frequently in patients with cancer, strictures, perforation, lye ingestion, Barrett’s esophagus, recurrent tracheoesophageal fistulas, and achalasia, accuracy is vital.

Store Images Easily for Further Review and Study

Images from Certes are sent to our cloud-based image repository and surgeon web portal powered by a trusted technology platform from ARMUS Corporation. Up to 10 imaging sequences can be stored for postprocedural review, ongoing learning, and remote consultation by colleagues in other locations.

We designed this revolutionary technology with an adamant belief in the power of learning and sharing knowledge. We believe this is the only way to elevate patient outcomes to the highest level possible.

Future developments currently under investigation expand our platform’s ability to use machine learning and future predictive analytics to expand the automatic analysis performed on every image.

Armed with even more data, surgeons can proceed with even more confidence.

See Certes in Clinical Use

Store Images Easily for Further Review and Study

Images from Certes are sent automatically to our cloud-based image repository and surgeon web portal powered by trusted software from ARMUS. Up to 10 imaging sequences can be stored for postprocedural review, ongoing learning, and remote consultation by colleagues in other locations.

We designed this revolutionary technology with an adamant belief in the power of learning and sharing knowledge. We believe this is the only way to elevate patient outcomes to the highest level possible.

Future developments currently under investigation expand our platform’s ability to use machine learning and future predictive analytics to expand the automatic analysis performed on every image.

Armed with even more data, surgeons can proceed with even more confidence.

See Certes in Clinical Use